| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/27/2004 | WO2004043406A2 ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS |
| 05/27/2004 | WO2004043398A2 Modulation of jumonji expression |
| 05/27/2004 | WO2004043395A2 Methods and compositions for treating neurological disorders |
| 05/27/2004 | WO2004043394A2 Modulation of huntingtin interacting protein 1 expression |
| 05/27/2004 | WO2004043391A2 Modulation of mitogen-activated protein kinase kinase kinase 11 expression |
| 05/27/2004 | WO2004043387A2 Compositions and methods for cancer diagnosis and therapy |
| 05/27/2004 | WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | WO2004043383A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | WO2004043376A2 Compositions and methods for treating or preventing pneumococcal infection |
| 05/27/2004 | WO2004043361A2 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | WO2004043344A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | WO2004043332A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043145A2 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 05/27/2004 | WO2004035616A3 Adenovirus expressing genes in reverse order and use thereof |
| 05/27/2004 | WO2004034780A3 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 05/27/2004 | WO2004033696A3 Recombinant adenoviral vectors and applications thereof |
| 05/27/2004 | WO2004029255A3 Squalene synthase 8sqs9 gen |
| 05/27/2004 | WO2004027065A3 Enone reductase gene and microbial production of levodione |
| 05/27/2004 | WO2004027015B1 Device and method for processing biological material |
| 05/27/2004 | WO2004024762A3 Il-8 like protein |
| 05/27/2004 | WO2004018626A3 Abasic site endonuclease assay |
| 05/27/2004 | WO2004016274B1 Novel peptide-conjugated oligomeric compounds |
| 05/27/2004 | WO2004013296A3 Cellular electromanipulation waveforms |
| 05/27/2004 | WO2004012851A3 Device for fast vibration of tubes containing samples |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004006855A3 Rhodococcus equi mutants and vaccines comprising same |
| 05/27/2004 | WO2004005890A3 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 05/27/2004 | WO2004001051A3 Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 05/27/2004 | WO2003104276A9 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 05/27/2004 | WO2003102239A3 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 05/27/2004 | WO2003102169B1 Anaerobe targeted enzyme-mediated prodrug therapy |
| 05/27/2004 | WO2003097842A8 Measure for non-homologous dna recombination process in mammalian cells |
| 05/27/2004 | WO2003089455A3 Low-cost production of peptides |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003076899A9 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 05/27/2004 | WO2003075833A3 Screening method for orthopoxvirus antivirals |
| 05/27/2004 | WO2003075655A3 Novel vip3 toxins and methods of use |
| 05/27/2004 | WO2003070888B1 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid |
| 05/27/2004 | WO2003060083A3 Cloning b and t lymphocytes |
| 05/27/2004 | WO2003054550A3 Uses of an endothelial cell receptor |
| 05/27/2004 | WO2003054229A3 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 05/27/2004 | WO2003044183A8 Interleukin-2 gene transferred lymphokine activated killer cells |
| 05/27/2004 | WO2003033685A3 Method of producing human beta cell lines |
| 05/27/2004 | WO2003033643A3 Three dimensional crystal structure of human sorbitol dehydrogenase and uses thereof |
| 05/27/2004 | WO2003031623A9 Cocoa flavour precursor peptides |
| 05/27/2004 | WO2003025177A3 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments |
| 05/27/2004 | WO2003015705A3 In situ immunization |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2003002155B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 05/27/2004 | WO2003001249A3 Modulating photoreactivity in a cell |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002097037A8 Melanin-concentrating hormone analogs |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002085923A3 In vivo incorporation of unnatural amino acids |
| 05/27/2004 | WO2002079393A3 Dynamic action reference tools |
| 05/27/2004 | WO2002072892A9 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| 05/27/2004 | WO2002055721B1 Modular transfection systems based on nucleoprotein filaments |
| 05/27/2004 | WO2002043478A8 Transgenic transchromosomal rodents for making human antibodies |
| 05/27/2004 | WO2001066563A3 T1r taste receptors and genes encoding same |
| 05/27/2004 | WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | WO1999042077A3 Compositions and methods for regulating lymphocyte activation |
| 05/27/2004 | US20040103457 Overexpression of phosphoenolpyruvate carboxylase |
| 05/27/2004 | US20040103456 Regulation of flavonoid expression in alfalfa using maize regulatory genes |
| 05/27/2004 | US20040103455 Comprises nucleotide sequences coding insecticidal protein for generation and propagation of insect resistant plants; biological pest control |
| 05/27/2004 | US20040103454 Transgenic plants containing molecular decoys that alter protein content therein |
| 05/27/2004 | US20040103453 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 05/27/2004 | US20040103452 Increasing proability of asexual reproduction in transgenic plants using nucleotide sequences coding somatic embryogenesis receptor kinase and auxin administration |
| 05/27/2004 | US20040103451 Comprises nucleotide sequences coding abscisic oxidoreductases for generation and propagation of disease and drought resistant plants |
| 05/27/2004 | US20040103450 Soybean mutant strain and soybean oil therefrom |
| 05/27/2004 | US20040103447 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 05/27/2004 | US20040102941 Methods, systems, and computer program products for simulating biomembrances using coarse grain models |
| 05/27/2004 | US20040102714 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 05/27/2004 | US20040102623 Modulation of PAK1 expression |
| 05/27/2004 | US20040102622 Modulation of hepatocyte growth factor receptor expression |
| 05/27/2004 | US20040102621 Modulation of forkhead box C2 expression |
| 05/27/2004 | US20040102618 Human RNase H1 and oligonucleotide compositions thereof |
| 05/27/2004 | US20040102613 For prophylactic/therapeutic drugs for heart/central nervous system diseases; diagnostic kits |
| 05/27/2004 | US20040102606 Histone H2A -derived peptides useful in gene delivery |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102413 Method and reagent for the inhibition of telomerase enzyme |
| 05/27/2004 | US20040102412 Antisense modulation of GFAT expression |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040102408 Method and medicament for inhibiting the expression of a given gene |
| 05/27/2004 | US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/27/2004 | US20040102406 Phosphorothioate oligonucleotides directed to a subunit of an integrin vitronectin receptor to inhibit angiogenesis and/or metastasis |
| 05/27/2004 | US20040102405 Using compounds comprising oligonucleotides targeted to nucleic acid encoding squalene synthase; for diagnosis and treatment of disease associated with expression of squalene synthase; cardiovascular disorders, atherosclerosis |
| 05/27/2004 | US20040102404 Modulation of KU86 expression |
| 05/27/2004 | US20040102403 Using compounds comprising oligonucleotides targeted to fibrillarin; for diagnosis and treatment of disease associated with expression of fibrillarin; proliferative disorders, cancer |
| 05/27/2004 | US20040102402 Using compounds comprising oligonucleotides targeted to nucleic acid encoding tissue factor; for diagnosis and treatment of disease associated with expression of tissue factor; cardiovascular disorders, cancer |
| 05/27/2004 | US20040102401 Using compounds comprising oligonucleotides targeted to nucleic acid encoding jagged 1; for diagnosis and treatment of disease associated with expression of jagged 1; developmental disorders, cancer |
| 05/27/2004 | US20040102400 Using compounds comprising oligonucleotides targeted to nucleic acid encoding UBE2G1; for diagnosis and treatment of disease associated with expression of UBE2G1; autoimmune, developmental, neurodegenerative disorders, cancer |
| 05/27/2004 | US20040102399 Using compounds comprising oligonucleotides targeted to nucleic acid encoding hypothetical protein 669; for diagnosis and treatment of disease associated with expression of hypothetical protein 669; metabolic disorders |
| 05/27/2004 | US20040102398 Using compounds comprising oligonucleotides targeted to nucleic acid encoding B7H; for diagnosis and treatment of disease associated with expression of B7H; autoimmune diseases |
| 05/27/2004 | US20040102397 Modulation of PPM1B expression |
| 05/27/2004 | US20040102396 Modulation of BCL2-associated athanogene 5 expression |
| 05/27/2004 | US20040102395 Modulation of IAP-like expression |